Affirm Results Presentation Deck

GAAP to Non-GAAP Expense Reconciliations, H2'21 ($ in 000s) Loss on loan purchase commitment Provision for credit losses Funding costs Processing and servicing Total Transaction Costs Technology and data analytics Sales and marketing General and administrative Other Operating Expenses Total Operating Expenses ($ in 000s) Loss on loan purchase commitment Provision for credit losses Funding costs Processing and servicing Total Transaction Costs Technology and data analytics Sales and marketing General and administrative Other Operating Expenses Total Operating Expenses $ $ $ $ $ $ $ $ $ $ GAAP GAAP 51,010 25,489 15,623 21,910 114,032 $ $ 69,128 $ 62,312 130,561 262,001 $ 376,033 $ 62,054 $ (1,063) 14,665 21,368 97,024 $ 104,806 58,184 179,999 342,989 $ 440,013 $ $ D&A D&A O O O 153 153 5,178 636 1,920 7.734 7,887 O O O 120 120 Compensation Expense $ $ $ $ $ $ $ Three Months Ended June 30, 2021 Stock-Based 3,655 $ 475 771 4,901 5,021 $ $ 0 0 O Compensation Expense 459 459 $ Enterprise Warrant & Share Based Expenses $ $ 19,817 5,183 74,685 99,685 $ 100,144 $ Three Months Ended March 31, 2021 Stock-Based 0 0 0 1,446 1,446 $ 52,058 $ 10,568 115,567 178,193 179,639 O O O Oc Enterprise Warrant & Share Based Expenses $ $ $ $ +A 0 $ 16,853 0 16,853 16,853 lo $ $ $ 0 $ 0 tA $ O $ 16,668 0 16,668 $ 16,668 $ Other Costs Other Costs O O O O O 0 $ O O OO O o o o o $ 3,582 3,582 3,582 $ 0 $ LA $ $ LA $ $ 12,953 12,953 $ 12,953 $ Non-GAAP 51,010 25,489 15,623 21,298 113,420 44,133 39,640 50,374 134,147 247,567 Non-GAAP 62,054 (1,063) 14,665 19,802 95,458 49,093 30,473 50,708 130,274 225,732 Notes: 1. FY Q3'21 and FY Q4'21 amounts include adjustments to amounts previously reported due to understatements in certain prior period amounts related to the fair value measurement of contingent consideration and stock-based compensation 37 affirm) 2. Other costs consists of one-time expenses incurred in the period associated with the Company's initial public offering, its acquisitions, and sublease impairment charges 3 Metrics are unaudited

View entire presentation